• Kehua Biotech reported the revenue of  Q1

    Kehua Biotech reported the revenue of Q1

    2019/04/28

    Recently, Kehua Biotech released the first quarter report of 2019. During the reporting period, the company realized the main business income of 506 million yuan, an increase of 11.8%; the net profit attributable to shareholders of listed co......More>>

  • Genetic Technologies, TGen to Launch Genetic Tests in US

    Genetic Technologies, TGen to Launch Genetic Tests in US

    2019/04/28

    Australian diagnostics firm Genetic Technologies said recently that it has signed a memorandum of understanding to commercialize its range of polygenic risk tests in the US with the Translational Genomics Research Institute. Under the terms......More>>

  • Thermo Fisher, NX Prenatal Partner on Pregnancy Outcome Assa

    Thermo Fisher, NX Prenatal Partner on Pregnancy Outcome Assa

    2019/04/28

    Thermo Fisher Scientific and NX Prenatal said recently that they have partnered on the development of mass spectrometry-based proteomics assays for adverse pregnancy outcomes. Under the terms of the deal, the companies will combine NXs NeXos......More>>

  • Yourgene Health to Acquire Elucigene for £9.2M in Cash, Stoc

    Yourgene Health to Acquire Elucigene for £9.2M in Cash, Stoc

    2019/04/28

    UK molecular diagnostics firm Yourgene Health said recently that it has agreed to acquire Elucigene for 9.2 million ($12.0 million) in cash and stock in a bid to bolster its presence in the noninvasive prenatal testing (NIPT) market. To fund......More>>

  • Natera Prices $100M Stock Offering

    Natera Prices $100M Stock Offering

    2019/04/28

    Natera announced recently that it has prices its $100 million common stock offering. The San Carlos, California-based molecular diagnostics firm is offering 5,263,158 shares of common stock at $19 per share. Gross proceeds from the offering......More>>

  • Danaher Q1 Revenues Up 4 Percent

    Danaher Q1 Revenues Up 4 Percent

    2019/04/28

    Danaher reported recetly a 4 percent year over year increase in total revenues paced by a 10 percent jump in the Life Sciences business. For the three months ending March 29, total revenues were $4.88 billion compared to $4.70 billion in the......More>>

Copyright © 2018 CACLP